Literature DB >> 17622179

Nonpeptidic ligands for peptide-activated G protein-coupled receptors.

Jade S Blakeney1, Robert C Reid, Giang T Le, David P Fairlie.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17622179     DOI： 10.1021/cr050984g

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  12 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

2.  Synthesis and cytotoxicity studies of 1-propenyl-1,3-dihydro-benzimidazol-2-one.

Authors:  Biswadip Banerji; Sumit Kumar Pramanik
Journal:  J Chem Biol       Date:  2015-04-17

3.  Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Engin Bojnik; Anna Borsodi; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  Mol Divers       Date:  2012-11-04       Impact factor: 2.943

Review 4.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

5.  Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions.

Authors:  Landon R Whitby; Yoshio Ando; Vincent Setola; Peter K Vogt; Bryan L Roth; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-06-15       Impact factor: 15.419

6.  Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).

Authors:  J Y Suen; G D Barry; R J Lohman; M A Halili; A J Cotterell; G T Le; D P Fairlie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.

Authors:  Harry R Chobanian; Yan Guo; Ping Liu; Marc Chioda; Thomas J Lanza; Linda Chang; Theresa M Kelly; Yanqing Kan; Oksana Palyha; Xiao-Ming Guan; Donald J Marsh; Joseph M Metzger; Judith N Gorski; Kate Raustad; Sheng-Ping Wang; Alison M Strack; Randy Miller; Jianmei Pang; Maria Madeira; Kathy Lyons; Jasminka Dragovic; Marc L Reitman; Ravi P Nargund; Linus S Lin
Journal:  ACS Med Chem Lett       Date:  2012-01-21       Impact factor: 4.345

8.  PAR2 Modulators Derived from GB88.

Authors:  Mei-Kwan Yau; Ligong Liu; Jacky Y Suen; Junxian Lim; Rink-Jan Lohman; Yuhong Jiang; Adam J Cotterell; Grant D Barry; Jeffrey Y W Mak; David A Vesey; Robert C Reid; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2016-10-10       Impact factor: 4.345

9.  Pathway-selective antagonism of proteinase activated receptor 2.

Authors:  J Y Suen; A Cotterell; R J Lohman; J Lim; A Han; M K Yau; L Liu; M A Cooper; D A Vesey; D P Fairlie
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 10.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.